15-90641158-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_022769.5(CRTC3):c.1610C>T(p.Pro537Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000285 in 1,613,954 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_022769.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CRTC3 | NM_022769.5 | c.1610C>T | p.Pro537Leu | missense_variant | 14/15 | ENST00000268184.11 | NP_073606.3 | |
CRTC3-AS1 | NR_120372.1 | n.393G>A | non_coding_transcript_exon_variant | 3/4 | ||||
CRTC3 | NM_001042574.3 | c.1610C>T | p.Pro537Leu | missense_variant | 14/15 | NP_001036039.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CRTC3 | ENST00000268184.11 | c.1610C>T | p.Pro537Leu | missense_variant | 14/15 | 1 | NM_022769.5 | ENSP00000268184 | P3 | |
CRTC3-AS1 | ENST00000559531.1 | n.394G>A | non_coding_transcript_exon_variant | 3/4 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152164Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 251254Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135836
GnomAD4 exome AF: 0.0000274 AC: 40AN: 1461790Hom.: 0 Cov.: 30 AF XY: 0.0000248 AC XY: 18AN XY: 727188
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152164Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74328
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 10, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at